Search

Your search keyword '"Sharpe, Rowena"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Sharpe, Rowena" Remove constraint Author: "Sharpe, Rowena"
18 results on '"Sharpe, Rowena"'

Search Results

1. The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

2. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

3. Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

4. The National Lung Matrix Trial of personalized therapy in lung cancer

5. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

6. TESSA JOWELL BRAIN MATRIX PLATFORM STUDY: PRELIMINARY ANALYSIS OF THE PRIMARY FEASIBILITY & PROCESS-CENTRED OBJECTIVE

8. Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer

9. The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

10. Protocol for the Tessa Jowell BRAIN MATRIX Platform Study

11. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

12. CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

13. Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

15. CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

17. Emerging findings in the Cancer Research UK stratified medicine program.

18. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

Catalog

Books, media, physical & digital resources